Is elevated platelet to high-density lipoprotein cholesterol ratio (PHR) associated with an increased risk of hypertension?
Elevated platelet to high-density lipoprotein cholesterol ratio (PHR) is associated with an increased risk of hypertension, suggesting its potential utility as an early biomarker for risk stratification.
Elevated PHR levels are strongly associated with an increased risk of hypertension. Specifically, when PHR is below 280, the risk of hypertension increases in proportion to PHR. This suggests that regular monitoring of PHR may help identify patients at risk of hypertension early, allowing for timely interventions to slow disease progression. Larger cohort studies are necessary to confirm these findings.
Chen et al. (Sat,) studied this question.